A. Genazzani

发表

Assessment of the prognostic relevance of serum anti-p53 antibodies in epithelial ovarian cancer.

M Ferdeghini, F. Buttitta, A. Gadducci, 1999, Gynecologic oncology.

In-vitro evidence of autocrine secretion of vascular endothelial growth factor by endothelial cells from human placental blood vessels.

A. Genazzani, R. Danesi, G. Bocci, 2001, Molecular human reproduction.

Malnutrition and cachexia in ovarian cancer patients: pathophysiology and management.

A. Gadducci, A. Fanucchi, S. Cosio, 2001, Anticancer research.

The HRT misuse and osteoporosis epidemic: a possible future scenario

A. Genazzani, M. Gambacciani, M. Ciaponi, 2007, Climacteric : the journal of the International Menopause Society.

Guidelines for the hormone treatment of women in the menopausal transition and beyondPosition statement by the Executive Committee of the International Menopause Society

H. Burger, A. Genazzani, F. Naftolin, 2004, Lijecnicki vjesnik.

Guidelines for hormone treatment of women in the menopausal transition and beyondPosition Statement by the Executive Committee of the International Menopause Society (Revised October 15, 2004)

H. Burger, A. Genazzani, F. Naftolin, 2004, Climacteric : the journal of the International Menopause Society.

The study with a million women (and hopefully fewer mistakes)

A. Genazzani, M. Gambacciani, 2003, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Growth hormone (GH)-releasing hormone-induced GH response in hypothalamic amenorrhea: evidence of altered central neuromodulation.

F. Petraglia, A. Genazzani, A. Genazzani, 1996, Fertility and sterility.

Increase of proopiomelanocortin-related peptides during subjective menopausal flushes.

F. Petraglia, A. Genazzani, F. Facchinetti, 1984, American journal of obstetrics and gynecology.

Treatment of postmenopausal vertebral osteopenia with monofluorophospate: A long-term calcium-controlled study

A. Genazzani, L. Rovati, M. Gambacciani, 2005, Osteoporosis International.

Peptide signaling in human placenta and membranes: autocrine, paracrine, and endocrine mechanisms.

C. Nappi, F. Petraglia, A. Genazzani, 1996, Endocrine reviews.

Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.

A. Gadducci, A. Genazzani, M. Gambacciani, 2001, Climacteric : the journal of the International Menopause Society.

Hormone replacement therapy and cancer

A. Gadducci, A. Genazzani, M. Gambacciani, 2001 .

Human GnRH-secreting cultured neurons express activin betaA subunit mRNA and secrete dimeric activin A.

F. Petraglia, A. Genazzani, G. Vannelli, 2000, European journal of endocrinology.

Episodic release of prolactin in women with weight loss-related amenorrhea.

F. Petraglia, A. Genazzani, N. Surico, 1994, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Modulatory role of estrogens and progestins on growth hormone episodic release in women with hypothalamic amenorrhea.

F. Petraglia, A. Genazzani, A. Genazzani, 1993, Fertility and sterility.

Effect of epimestrol on gonadotropin and prolactin plasma levels and response to luteinizing hormone-releasing hormone/thyrotropin-releasing hormone in secondary amenorrhea and oligomenorrhea.

A. Genazzani, V. de Leo, F. Facchinetti, 1978, Fertility and sterility.

Cardiovascular disease and hormone replacement therapy

A. Genazzani, M. Gambacciani, 2000 .

Prospective evaluation of calcium and estrogen administration on bone mass and metabolism after ovariectomy.

A. Genazzani, M. Ciaponi, G. Teti, 1995, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Hormone replacement therapy: the benefits in tailoring the regimen and dose.

A. Genazzani, M. Gambacciani, A. Genazzani, 2001, Maturitas.

Differential diagnosis of adnexal masses with transvaginal sonography, color flow imaging, and serum CA 125 assay in pre- and postmenopausal women.

A. Gadducci, M. Ferdeghini, A. Genazzani, 1996, Gynecologic oncology.

Neuroendocrinology of the human placenta

P. Sawchenko, F. Petraglia, L. Pecciarini, 1990 .

Human decidua and in vitro decidualized endometrial stromal cells at term contain immunoreactive corticotropin-releasing factor (CRF) and CRF messenger ribonucleic acid.

F. Petraglia, A. Genazzani, E. Gurpide, 1992, The Journal of clinical endocrinology and metabolism.

Evaluation of FHIT gene alterations in ovarian cancer.

A. Marchetti, F. Buttitta, A. Gadducci, 1998, British Journal of Cancer.

p53 status is neither a predictive nor a prognostic variable in patients with advanced ovarian cancer treated with a paclitaxel-based regimen.

F. Buttitta, A. Gadducci, A. Fanucchi, 2000, Anticancer research.

Effect of naltrexone treatment on the treadmill exercise-induced hormone release in amenorrheic women

F. Petraglia, A. Genazzani, R. Nappi, 1992, Journal of endocrinological investigation.

Hormone replacement therapy and cancer

A. Gadducci, A. Genazzani, M. Gambacciani, 2001 .

Sex-steroid hormones, gonadotropin and ovarian carcinogenesis: a review of epidemiological and experimental data

A. Gadducci, S. Cosio, A. Genazzani, 2004, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Low-dose hormone replacement therapy: effects on bone

A. Genazzani, M. Gambacciani, P. Monteleone, 2002, Climacteric : the journal of the International Menopause Society.

Effects of Org OD 14 on pituitary and peripheral beta-endorphin in castrated rats and post-menopausal women.

F. Petraglia, A. Genazzani, F. Facchinetti, 1987, Maturitas.

Increased HLA-DR homozygosity associated with pre-eclampsia.

A. Genazzani, M. Mariotti, L. Battini, 2000, Human reproduction.

Opioid control of gonadotrophin secretion in humans.

F. Petraglia, A. Genazzani, N. Surico, 1993, Human reproduction.

Cord plasma corticotropin-releasing factor-binding protein (CRF-BP) in term and preterm labour.

F. Petraglia, A. Genazzani, T. Simoncini, 1997, Placenta.

Effects of a new estrogen/progestin combination in the treatment of postmenopausal syndrome.

A. Genazzani, M. Gambacciani, M. Ciaponi, 1995, Maturitas.

Characteristics of headache at menopause: a clinico-epidemiologic study.

A. Genazzani, F. Facchinetti, F. Granella, 1993, Maturitas.

Premenstrual failure of alpha‐adrenergic stimulation on hypothalamus‐pituitary responses in menstrual migraine.

A. Genazzani, G. Sances, G. Nappi, 1989, Psychosomatic medicine.

Evidences for a dopamine-regulated peripheral source of circulating beta-endorphin.

F. Petraglia, A. Genazzani, F. Facchinetti, 1988, The Journal of clinical endocrinology and metabolism.

GH, IGFBP-1, and IGFBP-3 response to oral glucose tolerance test in perimenopausal women: no influence of body mass index.

F. Petraglia, M. Ferdeghini, A. Genazzani, 1999, Maturitas.

A personal initiative for women's health: to challenge the Women's Health Initiative

A. Genazzani, M. Gambacciani, 2002, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Activin A stimulates insulin secretion in cultured human pancreatic islets

P. Marchetti, F. Petraglia, A. Genazzani, 2000, Journal of endocrinological investigation.

Abnormal concentration of maternal serum activin-A in gestational diseases.

F. Petraglia, A. Genazzani, T. Woodruff, 1995, The Journal of clinical endocrinology and metabolism.

Expression and secretion of inhibin and activin in normal and neoplastic uterine tissues. High levels of serum activin A in women with endometrial and cervical carcinoma.

A. Gadducci, F. Petraglia, A. Genazzani, 1998, The Journal of clinical endocrinology and metabolism.

Pregnant patient with dermatomyositis successfully treated with intravenous immunoglobulin therapy.

S. Bombardieri, A. Genazzani, A. D'ascanio, 2005, Arthritis and rheumatism.

Peritoneal fluid levels of immunoreactive corticotropin-releasing factor (CRF) and CRF-binding protein (CRF-BP) in healthy and endometriosic women

F. Petraglia, A. Genazzani, P. Viganò, 1998, Journal of endocrinological investigation.

FSH secretory pattern and degree of concordance with LH in amenorrheic, fertile, and postmenopausal women.

F. Petraglia, A. Genazzani, F. Facchinetti, 1993, The American journal of physiology.

Pivagabine decreases stress-related hormone secretion in women with hypothalamic amenorrhea

F. Petraglia, A. Genazzani, S. Luisi, 2000, Journal of endocrinological investigation.

Spontaneous episodic release of adenohypophyseal hormones in hypothalamic amenorrhea.

F. Petraglia, A. Genazzani, A. Volpe, 1995, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

The duration of prolactin secretory bursts from the pituitary is independent from both prolactin and gonadal steroid plasma levels in women and in men

F. Petraglia, A. Genazzani, G. Forti, 1994, Journal of endocrinological investigation.

Intrinsic secretory characteristics of luteinizing hormone and prolactin episodic release during pubertal development.

F. Petraglia, A. Genazzani, N. Surico, 1994, European journal of endocrinology.

The concomitant release of androstenedione with cortisol and luteinizing hormone pulsatile releases distinguishes adrenal from ovarian hyperandrogenism.

F. Petraglia, A. Genazzani, A. Genazzani, 1993, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Neuroendocrine changes in luteal function in patients with premenstrual syndrome.

A. Genazzani, G. Nappi, F. Facchinetti, 1993, The Journal of clinical endocrinology and metabolism.

Growth hormone treatment affects plasma LH pulsatile release in women with secondary amenorrhoea

F. Petraglia, A. Genazzani, A. Genazzani, 1993, Clinical endocrinology.

Hypothalamic amenorrhea: evidence for a central derangement of hypothalamic-pituitary-adrenal cortex axis activity.

F. Petraglia, A. Genazzani, R. Nappi, 1993, Fertility and sterility.

Specific concordance index defines the physiological lag between LH and progesterone in women during the midluteal phase of the menstrual cycle.

F. Petraglia, A. Genazzani, A. Genazzani, 1991, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Luteinizing hormone (LH) secretory burst duration is independent from LH, prolactin, or gonadal steroid plasma levels in amenorrheic women.

F. Petraglia, A. Genazzani, A. Volpe, 1991, The Journal of clinical endocrinology and metabolism.

Evidence of luteinizing hormone secretion in hypothalamic amenorrhea associated with weight loss.

F. Petraglia, A. Genazzani, A. Genazzani, 1990, Fertility and sterility.

ESTIMATION OF INSTANTANEOUS SECRETORY RATE OF LUTEINIZING HORMONE IN WOMEN DURING THE MENSTRUAL CYCLE AND IN MEN

F. Petraglia, D. Rodbard, A. Genazzani, 1990, Clinical endocrinology.

Risk factors for type 2 diabetes in women attending menopause clinics in Italy: a cross-sectional study.

Sicilia, Emilia, Piemonte, 2005, Climacteric : the journal of the International Menopause Society.

Serum activin A levels in males and females during pubertal development

S. Bernasconi, F. Petraglia, A. Genazzani, 2001, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Identification of immunoreactive neuropeptide-gamma in human placenta: localization, secretion, and binding sites.

F. Petraglia, A. Genazzani, W. Vale, 1989, Endocrinology.

Mechanism of action of interleukin-1 beta in increasing corticotropin-releasing factor and adrenocorticotropin hormone release from cultured human placental cells.

F. Petraglia, A. Genazzani, L. Bilezikjian, 1990, American journal of obstetrics and gynecology.

Paracrine regulation of human placenta: control of hormonogenesis.

F. Petraglia, A. Genazzani, T. Simoncini, 1998, Journal of reproductive immunology.

Multiple Roles of Protein Kinase A in Arachidonic Acid–Mediated Ca2+ Entry and Tumor-Derived Human Endothelial Cell Migration

A. Genazzani, T. Genova, R. Zaninetti, 2010, Molecular Cancer Research.

Neuroendocrine effects of raloxifene hydrochloride in postmenopausal women

F. Petraglia, A. Genazzani, A. Genazzani, 2001, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Raloxifene analog LY 117018 effects on central and peripheral beta-endorphin.

F. Petraglia, A. Genazzani, S. Luisi, 1999, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Hormone replacement therapy and gynecological cancer.

A. Gadducci, A. Fanucchi, S. Cosio, 1997, Anticancer research.

HLA-DR in couples associated with preeclampsia: background and updating by DNA sequencing.

A. Genazzani, V. Valentino, M. Curcio, 2003, Journal of reproductive immunology.

Antagonism by pivagabine of stress-induced changes in GABAA receptor function and corticotropin-releasing factor concentrations in rat brain

G. Biggio, F. Petraglia, A. Genazzani, 1999, Psychoneuroendocrinology.

Preoperative D-dimer plasma assay is not a predictor of clinical outcome for patients with advanced ovarian cancer.

A. Gadducci, A. Fanucchi, M. Ferdeghini, 1997, Gynecologic oncology.

An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.

A. Gadducci, A. Fanucchi, S. Cosio, 2000, Anticancer research.

[Aerodiol: the efficacy and tolerability of intranasal estrogen administration. An overview].

A. Genazzani, M. Ciaponi, B. Cappagli, 2003, Minerva ginecologica.

Hormonal replacement therapy affects calcitonin gene-related peptide and atrial natriuretic peptide secretion in postmenopausal women.

F. Petraglia, A. Genazzani, S. Bertolini, 1997, European journal of endocrinology.

Long-term low-dose dehydroepiandrosterone replacement therapy in aging males with partial androgen deficiency

A. Genazzani, L. Rovati, A. Genazzani, 2004, The aging male : the official journal of the International Society for the Study of the Aging Male.

Clinical implications of circulating neurosteroids.

F. Petraglia, A. Genazzani, L. Cobellis, 2001, International review of neurobiology.

Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences.

F. Petraglia, A. Genazzani, R. Purdy, 1998, The Journal of clinical endocrinology and metabolism.

The missing R

A. Genazzani, M. Gambacciani, 2003, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Effect of acute corticotropin releasing factor on pituitary-adrenocortical responsiveness in elderly women and men

F. Petraglia, A. Genazzani, S. Luisi, 1998, Journal of endocrinological investigation.

Somatotropic axis and body weight in pre-menopausal and post-menopausal women: evidence for a neuroendocrine derangement, in absence of changes of insulin-like growth factor binding protein concentrations.

F. Petraglia, M. Ferdeghini, A. Genazzani, 1998, Human reproduction.

Effects of L-5HTP with and Without Carbidopa on Plasma ß-Endorphin and Pain Perception: Possible Implications in Migraine Prophylaxis

A. Genazzani, G. Sances, G. Nappi, 1986, Cephalalgia : an international journal of headache.

Activity of Hypothalamus-Pituitary-Adrenal Axis in Children with Hodgkin's Disease

F. Petraglia, A. Genazzani, C. Rota, 1988 .

Placental Stress Factors and Human Parturition

F. Petraglia, A. Genazzani, T. Simoncini, 1997, Annals of the New York Academy of Sciences.

Changes in amniotic fluid immunoreactive corticotropin-releasing factor (CRF) and CRF-binding protein levels in pregnant women at term and during labor.

F. Petraglia, A. Genazzani, P. Florio, 1997, The Journal of clinical endocrinology and metabolism.

High levels of corticotropin-releasing factor (CRF) are inversely correlated with low levels of maternal CRF-binding protein in pregnant women with pregnancy-induced hypertension.

F. Petraglia, A. Genazzani, C. Benedetto, 1996, The Journal of clinical endocrinology and metabolism.

Corticotropin-releasing hormone increases prostaglandin F2 alpha activity on human myometrium in vitro.

F. Petraglia, A. Genazzani, M. Massobrio, 1994, American journal of obstetrics and gynecology.

Efficacy on climacteric symptoms of a continuous combined regimen of 1 mg 17β-estradiol and trimegestone versus two regimens containing 1 or 2 mg 17β-estradiol and norethisterone acetate

A. Genazzani, M. Gambacciani, D. Spielmann, 2005, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Changes of opioid modulation of the hypothalamo‐pituitary‐adrenal axis in patients with severe premenstrual syndrome.

A. Genazzani, G. Sances, F. Facchinetti, 1994, Psychosomatic medicine.

The Association of Menstrual Migraine with the Premenstrual Syndrome

A. Genazzani, G. Nappi, F. Facchinetti, 1993, Cephalalgia : an international journal of headache.

Perimenstrual Headache Prophylaxis with Dihydroergokriptine

A. Genazzani, G. Sances, G. Nappi, 1991 .

Premenstrual fall of plasma β-endorphin in patients with premenstrual syndrome *

F. Petraglia, A. Genazzani, G. Nappi, 1987 .

Cytokines in placental physiology

F. Petraglia, A. Genazzani, S. Angioni, 1991 .

Activin A, corticotropin-releasing factor and prostaglandin F2 alpha increase immunoreactive oxytocin release from cultured human placental cells.

F. Petraglia, A. Genazzani, S. Sutton, 1996, Placenta.

Neuroendocrine evidence of deranged noradrenergic activity in chronic migraine

A. Genazzani, G. Sances, G. Nappi, 1989, Psychoneuroendocrinology.

Dysregulation of plasma pro-opiomelanocortin-related peptides in neurotic depression.

E. Sinforiani, F. Petraglia, A. Genazzani, 1986, Acta endocrinologica.

Lack of beta-endorphin plasma level rise in oxytocin-induced labor.

F. Petraglia, A. Genazzani, F. Facchinetti, 1985, Gynecologic and obstetric investigation.

Urocortin stimulates placental adrenocorticotropin and prostaglandin release and myometrial contractility in vitro.

F. Petraglia, A. Genazzani, W. Vale, 1999, The Journal of clinical endocrinology and metabolism.

Gonadotropin-releasing hormone, inhibin, and activin in human placenta: evidence for a common cellular localization.

F. Petraglia, A. Genazzani, W. Vale, 1992, The Journal of clinical endocrinology and metabolism.

ADRENAL AND GONADAL STEROIDS IN GIRLS DURING SEXUAL MATURATION

A. Genazzani, F. Facchinetti, U. Pelosi, 1978, Clinical endocrinology.

Opioid plasma levels in primary affective disorders. Effect of desimipramine therapy.

F. Petraglia, A. Genazzani, F. Facchinetti, 1984, Neuropsychobiology.

The brain as a target organ of gonadal steroids

N. Mercuri, F. Petraglia, A. Genazzani, 1992, Psychoneuroendocrinology.

Inhibin and activin in human fetal membranes: evidence for a local effect on prostaglandin release.

F. Petraglia, A. Genazzani, W. Vale, 1993, The Journal of clinical endocrinology and metabolism.

Naltrexone administration modulates the neuroendocrine control of luteinizing hormone secretion in hypothalamic amenorrhoea.

F. Petraglia, A. Genazzani, N. Surico, 1995, Human reproduction.

Molecular mechanisms of apoptosis and chemosensitivity to platinum and paclitaxel in ovarian cancer: biological data and clinical implications.

A. Gadducci, S. Cosio, A. Genazzani, 2002, European journal of gynaecological oncology.

Serum preoperative vascular endothelial growth factor (VEGF) in epithelial ovarian cancer: relationship with prognostic variables and clinical outcome.

A. Gadducci, A. Fanucchi, M. Ferdeghini, 1999, Anticancer research.

Activin A and inhibin B in extra-embryonic coelomic and amniotic fluids, and maternal serum in early pregnancy.

F. Petraglia, A. Genazzani, S. Luisi, 1998, Placenta.

Adrenal and gonadal steroids and pituitary response to LHRH in girls. I. Delayed puberty

A. Genazzani, F. Facchinetti, P. Fioretti, 1978, Journal of endocrinological investigation.

Dementia of the Alzheimer type and hypothalamus‐pituitary‐adrenocortical axis: changes in cerebrospinal fluid corticotropin releasing factor and plasma cortisol levels

F. Petraglia, A. Genazzani, G. Nappi, 1990, Acta neurologica Scandinavica.

Factors associated with total cholesterol levels in women around menopause attending menopause clinics in Italy

Mazzola, A. Pistoni, C. Belloni, 2004, Climacteric : the journal of the International Menopause Society.

Human placental beta-endorphin.

A. Genazzani, F. Fraioli, 1980, Gynecologic and obstetric investigation.

Effect of gonadectomy and gonadal steroid replacement on pituitary and plasma beta-endorphin levels in the rat.

D. Cocchi, F. Petraglia, A. Genazzani, 1982, Endocrinology.

Inhibin subunits in human placenta: localization and messenger ribonucleic acid levels during pregnancy.

F. Petraglia, A. Genazzani, W. Vale, 1991, American journal of obstetrics and gynecology.

Long-term GnRH-agonist administration revealed a GnRH-independent mechanism stimulating FSH discharge in humans.

F. Petraglia, A. Genazzani, A. Gandolfi, 1996, European journal of endocrinology.

Evidence suggesting an additional control mechanism regulating episodic secretion of luteinizing hormone and follicle stimulating hormone in pre-pubertal children and post-menopausal women.

F. Petraglia, A. Genazzani, A. Genazzani, 1994, Human reproduction.

Serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant v5 (sCD44-v5), and CD44 splice variant v6 (sCD44-v6) in patients with epithelial ovarian cancer.

A. Gadducci, A. Fanucchi, M. Ferdeghini, 1997, Anticancer research.

γ-Aminobutyric Acid Inhibits β-Endorphin Secretion from the Anterior Pituitary but not the Neurointermediate Lobe in the Rat

F. Petraglia, A. Genazzani, E. Müller, 1986 .

Analysis of the pattern of hypersensitivity reactions in patients receiving carboplatin retreatment for recurrent ovarian cancer

A. Gadducci, A. Fanucchi, A. Genazzani, 2007, International Journal of Gynecologic Cancer.

Disadaptive disorders in women: allopregnanolone, a sensitive steroid

A. Genazzani, A. Genazzani, N. Pluchino, 2004, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Opioid control of luteinizing hormone secretion in humans.

F. Petraglia, A. Genazzani, 1989, Journal of steroid biochemistry.

IMMUNOREACTIVE ACTH AND CORTISOL PLASMA LEVELS DURING PREGNANCY. DETECTION AND PARTIAL PURIFICATION OF CORTICOTROPHIN‐LIKE PLACENTAL HORMONE: THE HUMAN CHORIONIC CORTICOTROPIN (HCC)

A. Genazzani, J. Felber, P. Fioretti, 1975, Clinical endocrinology.

Autonomous beta-endorphin secretion from the pituitary neurointermediate lobe: in vivo studies.

D. Cocchi, F. Petraglia, A. Genazzani, 1984, Life sciences.

Presence and synthesis of inhibin subunits in human decidua.

F. Petraglia, A. Genazzani, W. Vale, 1990, The Journal of clinical endocrinology and metabolism.

Expression and secretion of inhibin and activin in normal and neoplastic uterine tissues

A. Gadducci, F. Petraglia, A. Genazzani, 1999 .

Serum levels of dimeric activin A are not a marker of placental tumors in the course of chemotherapy

F. Petraglia, J. Bidart, A. Genazzani, 1998, Journal of endocrinological investigation.

Maternal decidua and fetal membranes contain immunoreactive neuropeptide Y

C. Nappi, F. Petraglia, A. Genazzani, 1993, Journal of endocrinological investigation.

Activin A, inhibin A, inhibin B and parturition: changes of maternal and cord serum levels according to the mode of delivery

F. Petraglia, A. Genazzani, C. Benedetto, 1999, British journal of obstetrics and gynaecology.

Changes of dimeric inhibin B levels in maternal serum throughout healthy gestation and in women with gestational diseases.

S. Bernasconi, F. Petraglia, A. Genazzani, 1997, The Journal of clinical endocrinology and metabolism.

Serum activin A levels in males and females during pubertal development.

S. Bernasconi, F. Petraglia, A. Genazzani, 2001 .

Domperidone in defective and insufficient lactation.

F. Petraglia, A. Genazzani, V. de Leo, 1985, European journal of obstetrics, gynecology, and reproductive biology.

Relationship between cerebrospinal fluid β-endorphin and plasma pituitary-gonadal hormone levels in women

C. Nappi, F. Petraglia, A. Genazzani, 1990 .

Primary headaches: reduced circulating beta-lipotropin and beta-endorphin levels with impaired reactivity to acupuncture F. Facchinetti, G. Nappi, F. Savoldi and A.R. Genazzani, Cephalalgia, 1 (1981) 195–201

A. Genazzani, G. Nappi, F. Facchinetti, 1983, Pain.

Serum macrophage colony-stimulating factor (M-CSF) levels in patients with epithelial ovarian cancer.

A. Gadducci, M. Ferdeghini, C. Annicchiarico, 1998, Gynecologic oncology.

The clinical relevance of serum CYFRA 21-1 assay in patients with ovarian cancer

A. Gadducci, A. Fanucchi, M. Ferdeghini, 2001, International Journal of Gynecologic Cancer.

p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical study.

A. Marchetti, F. Buttitta, A. Gadducci, 1997, British Journal of Cancer.

Benign breast diseases, contraception and hormone replacement therapy.

A. Gadducci, A. Genazzani, M. Guerrieri, 2012, Minerva ginecologica.

Healthy women and patients with endometriosis show high concentrations of inhibin A, inhibin B, and activin A in peritoneal fluid throughout the menstrual cycle.

F. Petraglia, A. Genazzani, P. Viganò, 1998, Human reproduction.

Mainly mu-opiate receptors are involved in luteinizing hormone and prolactin secretion.

F. Petraglia, A. Genazzani, P. Sacerdote, 1985, Endocrinology.

Gonadal steroid modulation of naloxone-induced LH secretion in the rat.

D. Cocchi, F. Petraglia, A. Genazzani, 1984, The Journal of endocrinology.

Allopregnanolone concentration in hippocampus of prepubertal rats and female rats throughout estrous cycle

F. Petraglia, A. Genazzani, A. Genazzani, 1995, Journal of endocrinological investigation.

Steroid replacement treatment increases beta-endorphin and beta-lipotropin plasma levels in postmenopausal women.

F. Petraglia, A. Genazzani, F. Facchinetti, 1988, Gynecologic and obstetric investigation.

Naltrexone treatment restores menstrual cycles in patients with weight loss-related amenorrhea.

F. Petraglia, A. Genazzani, A R Genazzani, 1995, Fertility and sterility.

Lack of correlation between amniotic fluid and maternal plasma contents of beta-endorphin, beta-lipotropin, and adrenocorticotropic hormone in normal and pathologic pregnancies.

F. Petraglia, A. Genazzani, F. Facchinetti, 1984, American journal of obstetrics and gynecology.

Effect of two serotonin antagonists on prolactin release induced by breast stimulation in postpartum women.

I. Lancranjan, A. Genazzani, E. D. Del Pozo, 1979, Hormone research.

Prevalence of Postmenopausal Headache: A Prospective Study

A. Genazzani, F. Facchinetti, F. Granella, 1991 .

Stimulation of beta-endorphin and beta-lipotropin release from the anterior but not the neurointermediate pituitary lobe in the rat after acute administration of serotonin-acting drugs.

F. Petraglia, A. Genazzani, E. Müller, 1982, Life sciences.

Estetrol, a pregnancy-specific human steroid, prevents and suppresses mammary tumor growth in a rat model

E. Kubista, A. Genazzani, T. Simoncini, 2008, Climacteric : the journal of the International Menopause Society.

Pattern of plasma opioids in menstrually-related migraine and epilepsy.

L. Murri, U. Bonuccelli, A. Genazzani, 1986, Functional neurology.

Vascular endothelial growth factor and its soluble receptor in ovarian pathology

A. Genazzani, A. Genazzani, V. Cela, 2005, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Ontogeny of pituitary beta-endorphin and related peptides in the human embryo and fetus.

F. Petraglia, A. Genazzani, F. Facchinetti, 1987, American journal of obstetrics and gynecology.

Methodological problems and clinical validity of an ACTH radioimmunoassay method applied to extracted plasma samples.

A. Genazzani, P. Fioretti, C. Conti, 1974, The Journal of nuclear biology and medicine.

Low levels of serum inhibin A and inhibin B in women with hypergonadotropic amenorrhea and evidence of high levels of activin A in women with hypothalamic amenorrhea.

F. Petraglia, A. Genazzani, S. Kirchengast, 1998, Fertility and sterility.

Controversial issues in climacteric medicine I. Cardiovascular disease and hormone replacement therapy. International Menopause Society Expert Workshop. 13-16 October 2000, royal society of medicine, London, UK.

A. Genazzani, A R Genazzani, M. Gambacciani, 2000, Climacteric : the journal of the International Menopause Society.

Endocrine therapy for gynecological cancer.

A. Gadducci, A. Genazzani, 1999, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Hypothalamus pituitary-ovarian axis in menstrual migraine: effect of dihydroergotamine retard prophylactic treatment

E. Sinforiani, A. Genazzani, G. Sances, 1983 .

N‐terminal ACTH fragments increase the CSF β‐EP content in Alzheimer type dementia

E. Sinforiani, F. Petraglia, A. Genazzani, 1988, Acta neurologica Scandinavica.

Hormone replacement therapy and endometrial, ovarian and colorectal cancer.

A. Genazzani, M. Gambacciani, P. Monteleone, 2003, Best practice & research. Clinical endocrinology & metabolism.

Hyperendorphinemia in obese children and adolescents.

F. Petraglia, A. Genazzani, F. Facchinetti, 1986, The Journal of clinical endocrinology and metabolism.

Placental barrier breakage in preeclampsia: ultrastructural evidence.

A. Genazzani, P. Lenzi, A. Paparelli, 2005, European journal of obstetrics, gynecology, and reproductive biology.

Circulating beta–endorphin levels at various stages of life: possible connections with migraine pathogenesis

F. Petraglia, A. Genazzani, F. Facchinetti, 1983, Cephalalgia : an international journal of headache.

Neoadjuvant chemotherapy and concurrent chemoradiation in the treatment of advanced cervical cancer.

A. Gadducci, S. Cosio, A. Genazzani, 2001, Anticancer research.

Validation of Italian version of the Women's Health Questionnaire: assessment of quality of life of women from the general population and those attending menopause centers

C. Nappi, C. Campagnoli, P. Crosignani, 2002, Climacteric : the journal of the International Menopause Society.

Local production and action of follistatin in human placenta.

N. Ling, F. Petraglia, A. Genazzani, 1994, The Journal of clinical endocrinology and metabolism.

Preoperative serum intercellular adhesion molecule-1 (ICAM-1) and E-selectin (endothelial cell leukocyte adhesion molecule, ELAM-1) in patients with epithelial ovarian cancer.

A. Gadducci, M. Bianchi, M. Ferdeghini, 1995, Anticancer research.

Modifications in uterine and intraovarian artery impedance in cycles of treatment with exogenous gonadotropins: effects of luteal phase support.

A. Genazzani, F. Strigini, A. Visconti, 1995, Fertility and sterility.

Resistant Ovary Syndrome

A. Genazzani, P. Artini, F. Cristello, 2004 .

Opioid Control of Gonadotropin Secretion

F. Petraglia, A. Genazzani, S. Bettelli, 1990 .

Menopause and aging, quality of life and sexuality

A. Genazzani, T. Simoncini, M. Gambacciani, 2007, Climacteric : the journal of the International Menopause Society.

Chronobiological derangement of pituitary hormones in hypothalamic amenorrhea

F. Petraglia, A. Genazzani, N. Surico, 1996 .

Prolactin-Lowering Effect of Nomifensine in the Rat 1

D. Cocchi, A. Genazzani, V. Locatelli, 1979, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Factors associated with climacteric symptoms in women around menopause attending menopause clinics in Italy.

Angeloni, Ferrante, C. Campagnoli, 2005, Maturitas.

High levels of fetal membrane activin beta A and activin receptor IIB mRNAs and augmented concentration of amniotic fluid activin A in women in term or preterm labor.

F. Petraglia, A. Genazzani, W. Vale, 1997, The Journal of endocrinology.

Acute beta-interferon or thymopentin administration increases plasma growth hormone and cortisol levels in children.

F. Petraglia, A. Genazzani, S. Angioni, 1992, Acta endocrinologica.

Human umbilical vein endothelial cells: a new source and potential target for corticotropin-releasing factor.

F. Petraglia, A. Genazzani, T. Simoncini, 1999, The Journal of clinical endocrinology and metabolism.

Efficacy on hyperandrogenism and safety of a new oral contraceptive biphasic formulation containing desogestrel.

A. Genazzani, P. Deiana, A. Volpe, 1994, European journal of obstetrics, gynecology, and reproductive biology.

Platinum compounds and paclitaxel in advanced epithelial ovarian cancer.

A. Gadducci, S. Cosio, A. Genazzani, 1997, Anticancer Research.

Prothrombin fragment F1+2 and thrombin-antithrombin III complex (TAT) plasma levels in patients with gynecological cancer.

A. Gadducci, O. Gagetti, A. Genazzani, 1996, Gynecologic oncology.

Treatment options in patients with recurrent ovarian cancer.

A. Gadducci, A. Genazzani, P. Conte, 2001, Anticancer research.

Hormonal treatments modulate pulsatile plasma growth hormone, gonadotrophin and osteocalcin levels in postmenopausal women.

C. Nappi, N. Mercuri, F. Petraglia, 1993, Maturitas.

Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in endometrial cancer.

A. Gadducci, A. Fanucchi, M. Ferdeghini, 1996, Anticancer research.

Naproxen sodium in the treatment of premenstrual symptoms. A placebo-controlled study.

A. Genazzani, G. Sances, G. Nappi, 1989, Gynecologic and obstetric investigation.

Lack of gestation-related changes of urocortin gene expression in human placenta

F. Petraglia, A. Genazzani, T. Simoncini, 1999 .

UROCORTIN STIMULATES PLACENTAL ADRENOCORTICOTROPIN AND PROSTGLANDIN RELEASE AND MYOMETRICAL CONCTRACTILY

F. Petraglia, A. Genazzani, W. Vale, 1999 .

Placental impermeability to maternal ACTH in the rabbit

A. Genazzani, P. Fioretti, F. Fraioli, 1975, Experientia.

Exposure to low frequency pulsed electromagnetic fields increases interleukin-1 and interleukin-6 production by human peripheral blood mononuclear cells.

C. Franceschi, F. Petraglia, A. Genazzani, 1993, Experimental cell research.

The measurement of plasma D-dimer (DD) levels in the follow-up of patients with ovarian cancer.

A. Gadducci, A. Fanucchi, M. Ferdeghini, 1995, Anticancer research.

Is pretreatment hemoglobin level a predictor of complete response to salvage chemotherapy for recurrent platinum-pretreated ovarian carcinoma?

A. Gadducci, A. Fanucchi, S. Cosio, 2003, European journal of gynaecological oncology.

Plasma Opioid Levels in Post‐traumatic Chronic Headache and Trigeminal Neuralgia: Maintained Response to Acupuncture

F. Petraglia, A. Genazzani, G. Nappi, 1982, Headache.

Survival after intestinal obstruction in patients with fatal ovarian cancer: Analysis of prognostic variables

A. Gadducci, A. Fanucchi, S. Cosio, 1998 .

Gamma-glutamyltranspeptidase activity in human ovarian carcinoma.

A. Gadducci, F. Zunino, A. Genazzani, 1996, Anticancer research.

Prolactin changes after administration of agonist and antagonist dopaminergic drugs in puerperal women.

F. Petraglia, A. Genazzani, V. de Leo, 1987, Gynecologic and obstetric investigation.

Preoperative serum antibodies against the p53 protein in patients with ovarian and endometrial cancer.

F. Buttitta, A. Gadducci, A. Fanucchi, 1996, Anticancer Research.

Corticotropin-releasing hormone facilitates early survival of discordant (bovine-to-rat) islet xenografts.

P. Marchetti, F. Petraglia, A. Genazzani, 1998, Transplantation proceedings.

Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.

A. Gadducci, A. Genazzani, M. Gambacciani, 2001, Climacteric : the journal of the International Menopause Society.

Neuroendocrine evaluation of central opiate activity in primary headache disorders

F. Petraglia, G. Nappi, A. Genazzani, 1988, Pain.

Plasma and CSF Endorphin Levels in Primary and Symptomatic Headaches

F. Petraglia, A. Genazzani, G. Nappi, 1985, Headache.

Effect of weight loss on adrenal androgen plasma levels in obese prepubertal girls

A. Genazzani, C. Pintor, R. Puggioni, 1980 .

Naloxone Test In Primary Headache Sufferers

A. Genazzani, G. Nappi, F. Facchinetti, 1987, Cephalalgia : an international journal of headache.

Progressive impairment of CSF beta-EP levels in migraine sufferers.

F. Petraglia, A. Genazzani, G. Nappi, 1984, Pain.

Controversial issues in climacteric medicine IV Postmenopausal osteoporosis: therapeutic options

C. Christiansen, C. Campagnoli, J. Kanis, 2005 .